US adds more than 1M COVID-19 cases in November alone
The U.S. has surpassed 1 million new confirmed coronavirus cases in just the first 10 days of November, with more than 100,000 cases each day becoming the norm in a surge that shows no signs of slowing.
The U.S. has surpassed 1 million new confirmed coronavirus cases in just the first 10 days of November, with more than 100,000 cases each day becoming the norm in a surge that shows no signs of slowing.
COVID-19 vaccine timeline: A look at what’s ahead for leading candidates
Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.
Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.
Arizona ER doctor takes part in Pfizer COVID-19 vaccine trials
An emergency room doctor in Arizona says his role in the making of the Pfizer vaccine was done to provide a service to the community.
An emergency room doctor in Arizona says his role in the making of the Pfizer vaccine was done to provide a service to the community.
Pfizer says early data signals COVID-19 vaccine is 90% effective
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
COVID-19 vaccine: Who will get the first doses?
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
ViralClear halts trial of experimental treatment for hospitalized COVID-19 patients
Citing “an imbalance in survival rates,” ViralClear said it would halt a trial for COVID-19 patients who were given a combination of two experimental drugs in order to treat severe symptoms.
Citing “an imbalance in survival rates,” ViralClear said it would halt a trial for COVID-19 patients who were given a combination of two experimental drugs in order to treat severe symptoms.
FDA allows AstraZeneca’s COVID-19 vaccine trial to resume in US
The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.
The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.
Volunteer in AstraZeneca coronavirus clinical trial dies, report says
The volunteer was a man in his 20s, according to reports. It was not immediately clear if the man received the vaccine or had been part of a placebo group.
The volunteer was a man in his 20s, according to reports. It was not immediately clear if the man received the vaccine or had been part of a placebo group.
Pfizer to start testing COVID-19 vaccine in kids
Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.
Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.
Vaccines will be limited in supply and logistically challenging to distribute at first in California
"Don't expect you can go down the pharmacy during this calendar year and get a vaccine," Gov. Gavin Newsom said. "It is simply unrealistic. We don't anticipate mass availability until 2021."
"Don't expect you can go down the pharmacy during this calendar year and get a vaccine," Gov. Gavin Newsom said. "It is simply unrealistic. We don't anticipate mass availability until 2021."
Federal health officials planning to get coronavirus shots to nursing homes
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
FDA publishes COVID-19 vaccine guidelines opposed by White House
The FDA released updated safety standards for COVID-19 vaccines on Tuesday after the White House blocked their formal release.
The FDA released updated safety standards for COVID-19 vaccines on Tuesday after the White House blocked their formal release.
Moderna COVID-19 vaccine generates immune response in older adults, study finds
A study, published Tuesday in the New England Journal of Medicine, found that the experimental vaccine was well-tolerated and generated a strong immune response on older adults.
A study, published Tuesday in the New England Journal of Medicine, found that the experimental vaccine was well-tolerated and generated a strong immune response on older adults.
Researchers look to horseshoe crabs for help with a COVID vaccine
For decades, horseshoe crabs have played a role in vaccine development. Researchers are now looking at how they could help with a COVID vaccine.
For decades, horseshoe crabs have played a role in vaccine development. Researchers are now looking at how they could help with a COVID vaccine.
FDA chief says 'science will guide' decision on coronavirus vaccine approval
President Donald Trump is pushing for a fast decision. But Wednesday, the Food and Drug Administration's chief pledged to a Senate committee that the decision will be based on science, not politics.
President Donald Trump is pushing for a fast decision. But Wednesday, the Food and Drug Administration's chief pledged to a Senate committee that the decision will be based on science, not politics.
Medical experts concerned US not ready for COVID-19 vaccine
Health departments that have been underfunded for decades say they currently lack the staff, money and tools to educate people about vaccines and then to distribute, administer and track doses to some 330 million people.
Health departments that have been underfunded for decades say they currently lack the staff, money and tools to educate people about vaccines and then to distribute, administer and track doses to some 330 million people.
Officials detail plan to provide COVID-19 vaccines for free
The federal government is outlining a sweeping plan to make COVID-19 vaccines available for free to all Americans.
The federal government is outlining a sweeping plan to make COVID-19 vaccines available for free to all Americans.
Navajo Nation will participate in COVID-19 vaccine trials
“Several COVID-19 vaccine clinical trials are making progress across the U.S. and it’s important that the Navajo people have an opportunity to participate in a Phase 3 trial,” Navajo Nation President Jonathan Nez said in a statement.
“Several COVID-19 vaccine clinical trials are making progress across the U.S. and it’s important that the Navajo people have an opportunity to participate in a Phase 3 trial,” Navajo Nation President Jonathan Nez said in a statement.